Pages that link to "Q41824468"
Jump to navigation
Jump to search
The following pages link to Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. (Q41824468):
Displaying 50 items.
- Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin (Q21195679) (← links)
- Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review (Q24675281) (← links)
- Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value (Q24806041) (← links)
- Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis (Q24813085) (← links)
- Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity (Q24816615) (← links)
- 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis (Q26828418) (← links)
- The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis (Q26999006) (← links)
- Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort (Q31038073) (← links)
- A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity (Q33300467) (← links)
- Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study (Q33873636) (← links)
- Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis (Q34208191) (← links)
- Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis (Q34244715) (← links)
- Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis (Q34348712) (← links)
- Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts (Q34635933) (← links)
- Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis (Q34650192) (← links)
- Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis (Q34897056) (← links)
- Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles (Q35136055) (← links)
- Radiographic estimation in seropositive and seronegative rheumatoid arthritis (Q35184666) (← links)
- A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis (Q35207886) (← links)
- Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations (Q35553712) (← links)
- Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. (Q35554481) (← links)
- Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). (Q35554508) (← links)
- Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). (Q35554533) (← links)
- Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome (Q35554665) (← links)
- A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. (Q35554739) (← links)
- Prognostic laboratory markers of joint damage in rheumatoid arthritis (Q35555179) (← links)
- A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population (Q35555382) (← links)
- EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). (Q35638360) (← links)
- High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor alpha inhibitors in rheumatoid arthritis (Q35760039) (← links)
- Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? (Q35760091) (← links)
- Identification of two new arthritis severity loci that regulate levels of autoantibodies, interleukin-1β, and joint damage in pristane- and collagen-induced arthritis (Q35784822) (← links)
- A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis (Q35868959) (← links)
- Autoantibodies to citrullinated (poly)peptides: a key diagnostic and prognostic marker for rheumatoid arthritis (Q35934700) (← links)
- Rheumatoid arthritis: previously untreated early disease (Q36091751) (← links)
- ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome? (Q36183852) (← links)
- Evaluation of anti-mutated citrullinated vimentin antibodies, anti-cyclic citrullinated Peptide antibodies and rheumatoid factor in omani patients with rheumatoid arthritis (Q36184783) (← links)
- Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis (Q36226393) (← links)
- Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis (Q36245951) (← links)
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis (Q36395509) (← links)
- The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression (Q36475622) (← links)
- Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris (Q36733774) (← links)
- Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis (Q36740473) (← links)
- The immune response to citrullinated proteins in patients with rheumatoid arthritis: genetic, clinical, technical, and epidemiological aspects (Q36787712) (← links)
- Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis. (Q36790337) (← links)
- Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis (Q36960532) (← links)
- MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF. (Q37148403) (← links)
- Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis (Q37206919) (← links)
- The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases (Q37280952) (← links)
- Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers (Q37305188) (← links)
- Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis (Q37624583) (← links)